Alzheimer's disease (AD) is a highly neurodegenerative brain disease and is the most prevalent type of dementia. AD affects parts of brain that are responsible for memory, language and thought. Cholinergic hypothesis proposed that deficiency of acetylcholine in certain zones of brain may be responsible for the progressive memory deterioration observed in patient with AD. Therefore, inhibition of acetylcholinesterase (AChE) may represent a hopeful target for treatment of AD. Herein, new series of ring-fused benzimidazoles (benzimidazo [1,2-c] quinazoline derivatives (scheme 1, compounds 2a-d) and benzimidazo [2,1-c] triazole derivatives (scheme 2, compounds 7 and 8a-b) as main scaffolds) were synthesized using benzene1,2-diamine as a starting material and characterized by mass spectroscopy, IR, 1 HNMR, 13 C NMR and elemental analysis. Molecular docking studies were performed on AChE and demonstrated the preferential binding interaction of synthesized compounds with AChE binding site. Therefore, the obtained results imply that ring-fused benzimidazoles may act as an auspicious lead compounds for further optimization and biological evaluation against AChE.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.